Study services
The most expensive block in a registration budget, and the one where a protocol error is discovered latest.
What toxicity studies are required for pesticide registration in India?
A Section 9(3) new-molecule registration requires acute toxicity by oral, dermal and inhalation routes, irritation and sensitisation studies, sub-acute and longer-term studies as applicable to the molecule, and ecotoxicity data covering non-target organisms. Section 9(4) me-too applications generally do not require this programme, unless source equivalence cannot be established.
What the programme covers
| Block | Typical studies |
|---|---|
| Acute toxicity | Oral, dermal and inhalation LD₅₀ / LC₅₀ determination |
| Local effects | Skin irritation, eye irritation, skin sensitisation |
| Sub-acute and sub-chronic | Repeat-dose studies over defined periods, by the relevant route |
| Longer-term | Chronic toxicity, carcinogenicity, reproductive and developmental toxicity, as applicable |
| Genotoxicity | Mutagenicity test battery |
| Ecotoxicity | Fish, birds, honeybees, earthworms and other non-target organisms |
| Environmental fate | Soil and water persistence and degradation behaviour |
Which of these apply depends on the molecule, the formulation, the route of registration and the use pattern. A programme assembled by taking the full list and running everything wastes money; one assembled by guessing wastes a study cycle. The applicable set should be established by gap analysis against the requirements before anything is placed.
Three ways toxicology money is wasted
1. Studies run at unsuitable facilities
Data has to come from facilities whose output will be accepted, generated to appropriate protocols with proper documentation. A study conducted at a laboratory that does not meet the expected standard is not a partial saving — it is a full repeat, plus the elapsed time.
2. Protocols that do not match the requirement
Study design details — species, dose levels, duration, route, endpoints measured — have to align with what is required. A study that is technically sound but designed to a different guideline may not answer the question being asked. Review the protocol before the study starts, not the report after it finishes.
3. Expensive studies commissioned too early
This is the sequencing point, and it is the largest single source of avoidable loss. Long-term toxicology is the most expensive part of the programme. Running it before the bio-efficacy case is established, or before source equivalence is confirmed, means funding the most expensive block of a project that may not proceed.
Resolve the cheap questions that could kill the project first. Then fund the expensive ones.
Where toxicology is avoided entirely
For a Section 9(4) me-too registration, the toxicology accepted for the already-registered reference source generally covers your product — provided your material is equivalent. That is why source equivalence is the single largest cost variable in a me-too project.
If your impurity profile diverges materially from the reference, CIB&RC may require source-specific toxicology, which moves the project from the me-too cost bracket towards a new-molecule one. Screening a supplier's five-batch data before signing is therefore, in effect, toxicology risk management.
How JDR manages study programmes
- Establishing the applicable study set by gap analysis rather than by default
- Identifying existing data that can be relied on, including data generated for other markets
- Placing studies with accredited laboratories appropriate to each study type
- Reviewing protocols before work begins
- Monitoring studies in progress and reviewing draft reports
- Sequencing the programme so risk-reducing work precedes expensive work
- Integrating the reports into the dossier in the expected form
We would rather spend time on protocol review at the start than on explaining a deficient study at the query stage.
Frequently Asked Questions
Do I need toxicity studies for a me-too registration?
Generally not. The toxicology accepted for the already-registered reference source normally covers your product, provided your material is equivalent. Where equivalence cannot be established, source-specific studies may be required.
Can I use toxicology generated overseas?
Often yes. Toxicology data generated abroad frequently supports an Indian application, provided it was generated at an acceptable facility to appropriate protocols with adequate documentation. A gap analysis establishes what transfers.
Which studies should I commission first?
The ones that reduce risk cheaply — chemistry, equivalence screening, and enough bio-efficacy to know the claim is sound. Long-term toxicology is the most expensive block and should not be the first thing funded.
How long does the toxicology programme take?
Acute studies are comparatively quick. Sub-chronic, chronic, carcinogenicity and reproductive studies run considerably longer and typically extend furthest of any element in the programme.
What happens if a study is not accepted?
It has to be repeated, costing the study fee again plus the elapsed time. This is why protocol review before the study starts is worth more than report review after it finishes.
Reviewed: 22 September 2026 · Reflects the Insecticides Act, 1968 and Insecticides Rules, 1971 as amended, including the Insecticides Third (Amendment) Rules, 2026 (G.S.R. 597(E) dated 8 July 2026). General guidance only — confirm current requirements before acting.
Planning a toxicology programme?
Let us establish the applicable study set and the right sequence before you place a single study.
Talk to Our Regulatory Team